Metropolitan Life Insurance Company (MetLife)’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,579
| Closed | -$14.2K | – | 2072 |
|
|
2024
Q1 | $14.2K | Buy |
+2,579
| New | +$14.2K | ﹤0.01% | 2016 |
|
|
2023
Q4 | – | Sell |
-2,755
| Closed | -$95.7K | – | 2391 |
|
|
2023
Q3 | $95.7K | Buy |
2,755
+181
| +7% | +$6.29K | 0.01% | 1044 |
|
|
2023
Q2 | $84.4K | Buy |
2,574
+1,242
| +93% | +$40.7K | ﹤0.01% | 1111 |
|
|
2023
Q1 | $44.6K | Sell |
1,332
-180
| -12% | -$6.03K | ﹤0.01% | 1449 |
|
|
2022
Q4 | $49.6K | Hold |
1,512
| – | – | ﹤0.01% | 1482 |
|
|
2022
Q3 | $52.8K | Hold |
1,512
| – | – | ﹤0.01% | 1429 |
|
|
2022
Q2 | $18.5K | Buy |
+1,512
| New | +$18.5K | ﹤0.01% | 2077 |
|